Eli Lilly & Co. (LLY)
1247.64
-7.76
(-0.62%)
USD |
NYSE |
Aug 24, 16:00
1249.23
+1.60
(+0.13%)
After-Hours: 20:00
Eli Lilly EPS Diluted (Quarterly) : 7.939 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.939 |
| March 31, 2026 | 8.255 |
| December 31, 2025 | 7.024 |
| September 30, 2025 | 6.211 |
| June 30, 2025 | 6.291 |
| March 31, 2025 | 3.064 |
| December 31, 2024 | 4.654 |
| September 30, 2024 | 1.072 |
| June 30, 2024 | 3.281 |
| March 31, 2024 | 2.482 |
| December 31, 2023 | 2.306 |
| September 30, 2023 | -0.0638 |
| June 30, 2023 | 1.953 |
| March 31, 2023 | 1.489 |
| December 31, 2022 | 2.039 |
| September 30, 2022 | 1.606 |
| June 30, 2022 | 1.055 |
| March 31, 2022 | 2.099 |
| December 31, 2021 | 1.898 |
| September 30, 2021 | 1.219 |
| June 30, 2021 | 1.527 |
| March 31, 2021 | 1.485 |
| December 31, 2020 | 2.320 |
| September 30, 2020 | 1.326 |
| June 30, 2020 | 1.550 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.598 |
| December 31, 2019 | 1.635 |
| September 30, 2019 | 1.365 |
| June 30, 2019 | 1.44 |
| March 31, 2019 | 0.5702 |
| December 31, 2018 | 1.061 |
| September 30, 2018 | 1.066 |
| June 30, 2018 | -0.22 |
| March 31, 2018 | 1.112 |
| December 31, 2017 | -1.506 |
| September 30, 2017 | 0.53 |
| June 30, 2017 | 0.95 |
| March 31, 2017 | -0.10 |
| December 31, 2016 | 0.7011 |
| September 30, 2016 | 0.73 |
| June 30, 2016 | 0.71 |
| March 31, 2016 | 0.41 |
| December 31, 2015 | 0.4328 |
| September 30, 2015 | 0.75 |
| June 30, 2015 | 0.56 |
| March 31, 2015 | 0.50 |
| December 31, 2014 | 0.40 |
| September 30, 2014 | 0.47 |
| June 30, 2014 | 0.68 |
| March 31, 2014 | 0.68 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.268 |
| Merck & Co., Inc. | -0.5405 |
| Pfizer Inc. | -0.0435 |
| Bristol Myers Squibb Co. | 1.620 |
| Atai Beckley, Inc. | -0.0902 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.095B |
| Revenue (Quarterly) | 22.97B |
| Total Expenses (Quarterly) | 15.88B |
| Enterprise Value | 1.228T |
| Gross Profit Margin (Quarterly) | 85.78% |
| Profit Margin (Quarterly) | 30.88% |
| Earnings Yield | 2.36% |
| Operating Earnings Yield | 3.50% |
| Normalized Earnings Yield | 2.734 |